Congratulations to Paul Sondel, MD, PhD (Professor, Division of Hematology, Oncology & Bone Marrow Transplant), on being selected as UW-Madison’s nominee for the Association of Clinical and Translational Science (ACTS) 2021 Distinguished Investigator Award. Sondel was nominated by the Institute for Clinical and Translational Research (ICTR) leadership and its Awards Committee, with supporting letters from Howard Bailey, MD (Associate Dean for Oncology), and colleagues from the University of Washington and Children’s Hospital of Philadelphia. In its announcement of the nomination, the ICTR Awards Committee praised Sondel’s body of work in pediatric neuroblastoma, which resulted in the FDA approval of Dinutuximab for improved event-free survival.